Neptune Wellness Solutions Inc. (NEPTF) Financial Statements (2024 and earlier)
Company Profile
Business Address |
545 PROMENADE DU CENTROPOLIS LAVAL, QC H7T 0A3 |
State of Incorp. | QC |
Fiscal Year End | March 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
12/31/2023 MRQ | 3/31/2023 | 3/31/2022 | |||
---|---|---|---|---|---|
ASSETS | |||||
Current Assets | |||||
Cash, cash equivalents, and short-term investments | 2,011 | 8,746 | |||
Cash and cash equivalents | 1,993 | 8,726 | |||
Short-term investments | 18 | 19 | |||
Receivables | 5,700 | 6,988 | |||
Inventory, net of allowances, customer advances and progress billings | 13,006 | 17,059 | |||
Inventory | 13,006 | 17,059 | |||
Prepaid expense | 1,026 | 3,983 | |||
Other undisclosed current assets | 1,808 | 612 | |||
Total current assets: | 23,550 | 37,388 | |||
Noncurrent Assets | |||||
Operating lease, right-of-use asset | 1,941 | 2,295 | |||
Property, plant and equipment | 1,403 | 21,448 | |||
Intangible assets, net (including goodwill) | 4,033 | 43,823 | |||
Goodwill | 2,426 | 22,168 | |||
Intangible assets, net (excluding goodwill) | 1,607 | 21,655 | |||
Total noncurrent assets: | 7,378 | 67,567 | |||
TOTAL ASSETS: | 30,928 | 104,955 | |||
LIABILITIES AND EQUITY | |||||
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 20,526 | 10,668 | |||
Accounts payable | 20,526 | 10,668 | |||
Deferred revenue | 285 | ||||
Debt | 7,538 | ||||
Derivative instruments and hedges, liabilities | |||||
Estimated litigation liability | |||||
Other undisclosed current liabilities | 12,970 | 19,364 | |||
Total current liabilities: | 41,034 | 30,317 | |||
Noncurrent Liabilities | |||||
Long-term debt and lease obligation | 15,413 | 13,712 | |||
Long-term debt, excluding current maturities | 15,413 | 11,648 | |||
Liabilities, other than long-term debt | 2,042 | 89 | |||
Other liabilities | 24 | 89 | |||
Operating lease, liability | 2,018 | 2,063 | |||
Total noncurrent liabilities: | 17,455 | 13,800 | |||
Total liabilities: | 58,489 | 44,117 | |||
Equity | |||||
Equity, attributable to parent, including: | (11,940) | 48,116 | |||
Common stock | 321,946 | 317,051 | |||
Additional paid in capital | 58,139 | 55,980 | |||
Accumulated other comprehensive loss | (14,539) | (7,814) | |||
Accumulated deficit | (383,641) | (323,182) | |||
Warrants and rights outstanding | 3,156 | 5,571 | |||
Other undisclosed equity, attributable to parent | 2,999 | 509 | |||
Equity, attributable to noncontrolling interest | (15,621) | 12,722 | |||
Total equity: | (27,561) | 60,838 | |||
TOTAL LIABILITIES AND EQUITY: | 30,928 | 104,955 |
Income Statement (P&L) ($ in thousands)
12/31/2023 TTM | 3/31/2023 | 3/31/2022 | ||
---|---|---|---|---|
Revenues | 52,615 | 48,797 | ||
Cost of revenue (Cost of Goods and Services Sold) | (55,090) | (56,333) | ||
Gross profit: | (2,474) | (7,536) | ||
Operating expenses | (85,027) | (80,994) | ||
Other undisclosed operating loss | (15,346) | |||
Operating loss: | (102,848) | (88,530) | ||
Nonoperating income (expense) | 14,045 | 4,105 | ||
Investment income, nonoperating | 14,710 | 7,035 | ||
Gain (loss), foreign currency transaction, before tax | 6,435 | (686) | ||
Interest and debt expense | (35) | (540) | ||
Loss from continuing operations before equity method investments, income taxes: | (88,837) | (84,965) | ||
Other undisclosed income from continuing operations before income taxes | 35 | 540 | ||
Loss from continuing operations before income taxes: | (88,803) | (84,425) | ||
Other undisclosed income from continuing operations | ||||
Loss from continuing operations: | (88,803) | (84,425) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | (84,425) | |
Net loss: | (88,803) | (84,425) | ||
Net income attributable to noncontrolling interest | 28,343 | 9,453 | ||
Net loss available to common stockholders, diluted: | (60,460) | (74,972) |
Comprehensive Income ($ in thousands)
12/31/2023 TTM | 3/31/2023 | 3/31/2022 | ||
---|---|---|---|---|
Net loss: | (88,803) | (84,425) | ||
Other comprehensive income (loss) | (6,725) | 750 | ||
Comprehensive loss: | (95,527) | (83,674) | ||
Comprehensive income, net of tax, attributable to noncontrolling interest | 28,343 | 9,455 | ||
Comprehensive loss, net of tax, attributable to parent: | (67,184) | (74,219) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.